NASDAQ:BEAM

Beam Therapeutics (BEAM) Earnings Date, Estimates & Call Transcripts

$33.45

-0.91 (-2.65%)

(As of 06/8/2023 ET)

Compare

Today's Range: $32.81
▼
$34.66
50-Day Range: $29.32
▼
$35.99
52-Week Range: $28.04
▼
$73.27

Volume: 491,356 shs
Average Volume: 888,383 shs
Market Capitalization: $2.55 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $67.91

Upcoming Earnings Date: Aug. 8Estimated
Actual EPS (May. 10): -$1.33 Beat By $0.03
Consensus EPS (May. 10): -$1.36
Last Year's Q2 EPS (5/9/2022): -$1.01

Earnings Per Share Revenue

BEAM Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BEAM Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Beam Therapeutics Analyst Forecasts

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2023	4	($1.61)	($1.20)	($1.40)
Q2 2023	4	($1.51)	($1.15)	($1.34)
Q3 2023	4	($1.56)	($1.15)	($1.33)
Q4 2023	4	($1.63)	($1.01)	($1.36)
FY 2023	16	($6.31)	($4.51)	($5.42)
Q1 2024	2	($1.65)	($1.09)	($1.37)
Q2 2024	2	($1.74)	($1.16)	($1.45)
Q3 2024	2	($1.64)	($1.18)	($1.41)
Q4 2024	2	($1.67)	($1.24)	($1.46)
FY 2024	8	($6.70)	($4.67)	($5.69)

BEAM Earnings Date and Information

Beam Therapeutics last issued its earnings data on May 10th, 2023. The reported ($1.33) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.36) by $0.03. The firm had revenue of $24.21 million for the quarter, compared to the consensus estimate of $14.41 million. Beam Therapeutics has generated ($4.45) earnings per share over the last year (($4.45) diluted earnings per share). Earnings for Beam Therapeutics are expected to decrease in the coming year, from ($5.50) to ($6.00) per share. Beam Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 8th, 2023 based off prior year's report dates.

Beam Therapeutics Earnings History by Quarter

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
8/8/2023 (Estimated)
5/10/2023	Q1 2023	($1.36)	($1.33)	+$0.03	($1.33)	$14.41 million	$24.21 million
2/28/2023	Q4 2022	($1.34)	($0.54)	+$0.80	($0.54)	$12.73 million	$20.04 million
11/7/2022	Q3 2022	($1.30)	($1.56)	($0.26)	($1.56)	$7.15 million	$15.80 million
8/9/2022	Q2 2022	($1.08)	($1.02)	+$0.06	($1.02)	$9.44 million	$16.65 million
5/9/2022	Q1 2022	($1.10)	($1.01)	+$0.09	($1.01)	$44.15 million	$8.40 million
2/28/2022	Q4 2021	($1.02)	($0.85)	+$0.17	($0.75)	$9.58 million	$51.07 million

11/7/2021	9/30/2021	($0.72)	($0.42)	+$0.30	($0.42)	$15.88 million	$0.76 million
8/9/2021	6/30/2021	($0.74)	($1.23)	($0.49)	($0.67)	$8.33 million	$0.01 million
5/10/2021	3/31/2021	($0.74)	($3.35)	($2.61)	($3.35)	$6.00 million	$0.01 million
3/14/2021	12/31/2020	($0.66)	($1.69)	($1.03)	$0.25	$6.00 million	$0.01 million
11/10/2020	Q3 2020	($0.57)	($0.69)	($0.12)	($0.69)	$0.01 million	$0.01 million
11/10/2020	9/30/2020	($0.55)	($0.69)	($0.14)	($0.69)	$0.01 million	$0.01 million
8/12/2020	Q2 2020	($0.56)	($0.69)	($0.13)	($0.69)	$0.01 million	$0.01 million
8/12/2020	6/30/2020	($0.52)	($0.69)	($0.17)	($0.69)	$0.01 million	$0.01 million
5/12/2020	Q1 2020	($0.55)	($1.03)	($0.48)	($1.03)		$0.01 million
5/12/2020	3/31/2020	($0.51)	($1.03)	($0.52)	($1.03)		$0.01 million
2/5/2014	Q413	$0.72	$0.77	+$0.05	$0.99	$735.47 million	$739.50 million
10/31/2013	Q3 2013	$0.59	$0.59		$0.66	$630.82 million	$598.70 million
8/8/2013	Q2 2013	$0.60	$0.64	+$0.04	$0.82	$628.58 million	$637.60 million
5/2/2013	Q1 2013	$0.54	$0.64	+$0.10	$0.57	$565.93 million	$577.70 million
2/1/2013	Q4 2012	$0.66	$0.67	+$0.01		$704.12 million	$709.10 million
11/2/2012	Q312	$0.55	$0.62	+$0.07		$607.25 million	$627.50 million
8/2/2012		$0.54	$0.58	+$0.04
5/3/2012		$0.47	$0.19	($0.28)
2/3/2012		$0.67	$0.69	+$0.02
11/3/2011		$0.50	$0.53	+$0.03
8/4/2011	Q2 2011	$0.97	$0.93	($0.04)	($0.23)
5/5/2011	Q1 2011	$0.51	$0.59	+$0.08	$0.66
2/4/2011	Q4 2010	$0.58	$0.63	+$0.05	$0.71
10/28/2010	Q3 2010	$0.74	$0.72	($0.02)	$0.78
7/30/2010	Q2 2010	$0.77	$0.99	+$0.22	$0.50
4/29/2010	Q1 2010	$0.31	$0.49	+$0.18	$0.51
1/29/2010	Q4 2009	$0.51	$0.66	+$0.15	$1.24
10/23/2009	Q3 2009	$0.63	$0.77	+$0.14	$0.72
7/24/2009	Q2 2009	$0.64	$0.70	+$0.06	$0.74
5/1/2009	Q1 2009	$0.30	$0.30		$0.55
1/29/2009	Q4 2008	$0.85	$0.68	($0.17)	$3.20
10/24/2008	Q3 2008	$1.09	$1.11	+$0.02	$0.01
7/25/2008	Q2 2008	$1.20	$1.25	+$0.05	$1.62
4/24/2008	Q1 2008	$0.79	$0.75	($0.04)	$0.73

1/25/2008	Q4 2007	$1.44	$1.43	($0.01)	$1.58

Beam Therapeutics Earnings - Frequently Asked Questions

When is Beam Therapeutics's earnings date?: Beam Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 8th, 2023 based off last year's report dates. Learn more on BEAM's earnings history.
Did Beam Therapeutics beat their earnings estimates last quarter?: In the previous quarter, Beam Therapeutics (NASDAQ:BEAM) reported ($1.33) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.36) by $0.03. Learn more on analysts' earnings estimate vs. BEAM's actual earnings.

How much revenue does Beam Therapeutics generate each year?: Beam Therapeutics (NASDAQ:BEAM) has a recorded annual revenue of $60.92 million.
How much profit does Beam Therapeutics generate each year?: Beam Therapeutics (NASDAQ:BEAM) has a recorded net income of -$289.09 million. BEAM has generated -$4.45 earnings per share over the last four quarters.
What is Beam Therapeutics's EPS forecast for next year?: Beam Therapeutics's earnings are expected to decrease from ($5.50) per share to ($6.00) per share in the next year.

More Earnings Resources from MarketBeat

Related Companies:

Earnings Tools:

Earnings By Country:

Latest Articles:

This page (NASDAQ:BEAM) was last updated on 6/9/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Beam Therapeutics (BEAM) Earnings Date, Estimates & Call Transcripts

BEAM Earnings Estimates and Actuals by Quarter

BEAM Estimated and Actual Revenue by Quarter

Beam Therapeutics Analyst Forecasts

BEAM Earnings Date and Information

Beam Therapeutics Earnings History by Quarter

Beam Therapeutics Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info

Beam Therapeutics (BEAM) Earnings Date, Estimates & Call Transcripts

Earnings Summary

BEAM Earnings Estimates and Actuals by Quarter

BEAM Estimated and Actual Revenue by Quarter

Beam Therapeutics Analyst Forecasts

BEAM Earnings Date and Information

Beam Therapeutics Earnings History by Quarter

Beam Therapeutics Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat